McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
NVS holding history
Novartis AG in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q1 2026 holdings
- Shares (Q1 2026)
- 375
- Value
- $57.3K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 375 | $57.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 375 | $51.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 375 | $48.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 375 | $45.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 375 | $41.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 375 | $36.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 375 | $43.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 375 | $39.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 375 | $36.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 375 | $37.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 375 | $38.2K | <0.1% | +100+36.4% | Added | Holders |
| Q2 2023 | 275 | $27.8K | <0.1% | −686−71.4% | Reduced | Holders |
| Q1 2023 | 961 | $88.4K | <0.1% | +16+1.7% | Added | Holders |
| Q4 2022 | 945 | $85.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 945 | $72.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 945 | $80.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 945 | $83.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 945 | $83.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 945 | $77.0K | <0.1% | +516+120.3% | Added | Holders |
| Q2 2021 | 429 | $39.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 429 | $37.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.